Literature DB >> 16396227

[Epidemiology of Alzheimer's disease].

Carole Dufouil1, Annick Alpérovitch.   

Abstract

Because of global ageing of the population, the occurrence of Alzheimer's disease (AD) cases is increasing dramatically and AD is becoming a major public health preoccupation. By the year 2020, the World Health Organisation predicts that there will be almost 29 millions demented people throughout the world, two third of them being AD cases. This dramatic perspective could only be modified with new curative treatments or prevention. These last years, there is increasing evidence from epidemiological studies for the role of vascular risk factors in the aetiology of AD among which hypertension, type 2 diabetes, or high cholesterol. These potentially modifiable risk factors raise hope for prevention of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16396227

Source DB:  PubMed          Journal:  Rev Prat        ISSN: 0035-2640


  4 in total

Review 1.  An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.

Authors:  Xiaoling Zhou; Yifei Li; Xiaozhe Shi; Chun Ma
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease.

Authors:  Balmiki Ray; Savita Bisht; Amarnath Maitra; Anirban Maitra; Debomoy K Lahiri
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Variability in the diagnosis and management of patients with Alzheimer's disease and cerebrovascular disease: results from the GALATEA multicentre, observational study.

Authors:  Pedro Gil; José Luis Dobato Ayuso; José Manuel Marey; Manuel Antón; Carlos Guzmán Quilo
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 4.  Systematic Review of Basic Research on Alzheimer's Disease with Shen Zhi Ling Oral Liquid.

Authors:  Yahan Wang; Chunxiang Liu; Hui Wang; Yin Jiang; Pengwen Wang; Hongcai Shang
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-21       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.